chr7-117536514-AGATTGATTGATT-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_000492.4(CFTR):c.744-17_744-6delGATTGATTGATT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000104 in 1,541,396 control chromosomes in the GnomAD database, with no homozygous occurrence. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 25)
Exomes 𝑓: 0.000010 ( 0 hom. )
Consequence
CFTR
NM_000492.4 splice_region, intron
NM_000492.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.82
Genes affected
CFTR (HGNC:1884): (CF transmembrane conductance regulator) This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFTR | NM_000492.4 | c.744-17_744-6delGATTGATTGATT | splice_region_variant, intron_variant | ENST00000003084.11 | NP_000483.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFTR | ENST00000003084.11 | c.744-17_744-6delGATTGATTGATT | splice_region_variant, intron_variant | 1 | NM_000492.4 | ENSP00000003084.6 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151648Hom.: 0 Cov.: 25
GnomAD3 genomes
AF:
AC:
2
AN:
151648
Hom.:
Cov.:
25
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000612 AC: 10AN: 163440Hom.: 0 AF XY: 0.000104 AC XY: 9AN XY: 86906
GnomAD3 exomes
AF:
AC:
10
AN:
163440
Hom.:
AF XY:
AC XY:
9
AN XY:
86906
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000101 AC: 14AN: 1389630Hom.: 0 AF XY: 0.0000145 AC XY: 10AN XY: 687334
GnomAD4 exome
AF:
AC:
14
AN:
1389630
Hom.:
AF XY:
AC XY:
10
AN XY:
687334
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151766Hom.: 0 Cov.: 25 AF XY: 0.0000135 AC XY: 1AN XY: 74148
GnomAD4 genome
AF:
AC:
2
AN:
151766
Hom.:
Cov.:
25
AF XY:
AC XY:
1
AN XY:
74148
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Jan 19, 2024 | The CFTR c.744-17_744-6del variant (also known as IVS6GATT[4]) has been reported in the published literature in an individual affected with pancreatic-insufficient cystic fibrosis who also carried the p.Phe508del (also known as DeltaF508) variant (PMID: 7683952 (1993)). This variant was also identified in reportedly healthy individuals (PMIDs: 11104661 (2001), 20233062 (2010)). Studies of related variants (i.e. GATT[7] and GATT[6]) have observed minor aberrations in the splicing of exon 7 (PMIDs: 26075213 (2015), 35988290 (2022)). The frequency of the GATT[4] variant in the general population, 0.00072 (9/12522 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using software algorithms for the prediction of the effect of nucleotide changes on CFTR mRNA splicing yielded inconclusive findings. Based on the available information, we are unable to determine the clinical significance of this variant. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at